martes, 29 de noviembre de 2016

American Diabetes Month 4 | National Guideline Clearinghouse 4

American Diabetes Month 4 | National Guideline Clearinghouse 4
Search | National Guideline Clearinghouse
ngc

Health Awareness Topics: November 2016

61-80 of 103 results for

“Endocrine System Diseases”

  • GUIDELINE SUMMARY
  •  
  • NGC:010217
  •  
  • 2008 JUL-AUG (REVISED 2013 MAR-APR)

Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient - 2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic and Bariatric Surgery.

  • GUIDELINE SUMMARY
  •  
  • NGC:010370
  •  
  • 2009 (REVISED 2012 MAY)

Guidelines for the management of absolute cardiovascular disease risk.

  • GUIDELINE SUMMARY
  •  
  • NGC:009499
  •  
  • 2007 (REVISED 2012)

Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline.

  • GUIDELINE SUMMARY
  •  
  • NGC:010790
  •  
  • 2011 MAR (REVISED 2015 AUG 26)

Diabetic foot problems: prevention and management.

  • GUIDELINE SUMMARY
  •  
  • NGC:009371
  •  
  • 1996 (REVISED 2013 JAN 1)

Menopausal hormone therapy for the primary prevention of chronic conditions: U.S. Preventive Services Task Force recommendation statement.

  • GUIDELINE SUMMARY
  •  
  • NGC:010947
  •  
  • 2015

Diabetes type 1 and type 2 evidence-based nutrition practice guideline.

  • GUIDELINE SUMMARY
  •  
  • NGC:007748
  •  
  • 2002 (REVISED 2008; REAFFIRMED 2013 JUN)

Clinical practice guidelines on arterial hypertension. 2007 update.

  • GUIDELINE SUMMARY
  •  
  • NGC:009630
  •  
  • 2013 APR

Ranibizumab for treating diabetic macular oedema (rapid review of technology appraisal guidance 237).

  • GUIDELINE SUMMARY
  •  
  • NGC:009220
  •  
  • 1995 (REVISED 2012)

ACR Appropriateness Criteria® suspected osteomyelitis of the foot in patients with diabetes mellitus.

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012.

  • GUIDELINE SUMMARY
  •  
  • NGC:009946
  •  
  • 2013 JUN

Dapagliflozin in combination therapy for treating type 2 diabetes.

  • GUIDELINE SUMMARY
  •  
  • NGC:006977
  •  
  • 2009 JAN (REAFFIRMED 2013 JAN)

Practice parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review).

  • GUIDELINE SUMMARY
  •  
  • NGC:009150
  •  
  • 2002 (REVISED 2012 JUN)

The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.

  • GUIDELINE SUMMARY
  •  
  • NGC:010231
  •  
  • 2013 DEC

Prenatal care.

  • GUIDELINE SUMMARY
  •  
  • NGC:008638
  •  
  • 2002 (REVISED 2011)

Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus.

  • GUIDELINE SUMMARY
  •  
  • NGC:009111
  •  
  • 2004 OCT 1 (REVISED 2012 JUN)

2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections.

  • GUIDELINE SUMMARY
  •  
  • NGC:008998
  •  
  • 2002 OCT 6 (REVISED 2012 MAR)

The 2012 hormone therapy position statement of The North American Menopause Society.

No hay comentarios:

Publicar un comentario en la entrada